Therapeutics

PTx is a biopharmaceutical company committed to the development and commercialization of therapies that improve the treatment of cancer.

CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, in 40 countries worldwide, both directly and through strateg

At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the trea

Salvia is an innovative start-up active in the emerging field of BioElectronics.

Scout Bio is a biotechnology company that specializes in veterinary, animal health, and gene therapy. The company is driven by its mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine.Scout Bio was founded in 2016 and headquartered in

Onkos functions to provide proprietary gene expression-based diagnostic tests that focused on providing answers to diagnostic uncertainties in Oncology. They deliver answers that give practical and objective support to clinical decision-making, providing better clinical management and improving the

coding.bio is accelerating Cell Therapy using AI and synthetic biology driven discovery

LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary resear

TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of i

We discover the 1 in a million 10,000x faster. Harnessing evolution means giving nature the time and space to find complex solutions. Current technology falls fall short of the scale required to accelerate this process. The current state of the art is to rely on technology like liquid-handling robot

Your next level partners: Uniquely skilled and dedicated to your success. Leading therapy providers turn to Enhance Therapies because we partner with them to provide excellent care and exceptional service. With a focus on patients and innovation, we support our partners with the necessary resources

Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggab

Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our purpose is to turn untapped potential into global medical therapies that impr

We’re 4 MIT engineers who started Encora to research wearable solutions for patients with movement disorders. We’re leveraging advances in wearable technology, signal processing, reinforcement learning, and patient sensing to provide affordable, personalized, non-invasive remedies for patients with

Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help imp

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

Medzown is precision medicine management at scale. We use advanced analytics and deep expertise to bridge the gap between patients and treatments like immunotherapies, targeted therapies, cell and gene therapies, and clinical trials. At the same time, we deliver exceptional return on investment for

Pioneering, proven pain treatment for knee OA. Arthrosamid® — The first and only synovial scaffold administered via a single injectable for long-lasting pain relief. Arthrosamid® is a single, minimally invasive, long-lasting knee OA treatment — a non-biodegradable injectable polyacrylamide hydrog

TatvaCare is transforming care practices to deliver positive health outcomes. TatvaCare, a startup in the Indian health tech landscape, is catalyzing the transformation of care practices through digitisation. Our product portfolio includes TatvaPractice, an advanced EMR and Knowledge platform for he

PHARMO Institute for Drug Outcomes Research uses patient-centric data to derive real-life insights into value of medicines for the individual patients. We provide tailor-made research solutions to questions on Disease Epidemiology, Drug Utilization Research, Utilization of Healthcare Resources, Heal

Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Moslicig

Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced proprietary transdermal technology. Based in Surrey, UK, the company's shares trade on the AIM market of the London Stock Exchange. Futura's development pipeline focus

Faeth Therapeutics is a data-driven company that focuses on using metabolism to rethink the science of cancer.

At Polonium Foundation we are turning Polish brain drain into brain circulation by unlocking the potential of Polish research diaspora. We connect its members at our events, research the community, and provide policy recommendations.

Neunos Ltd is combining the latest advances of neuroscience with cutting-edge microelectronic approaches in order to provide a therapeutic solution based on oscillatory interference with ongoing neuronal network activity. We develop a minimally-invasive, implantable seizure suppression system, which

MYOS develops and commercializes nutritional supplements, functional food and therapeutic products that maximize muscle health.

Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powered Address, Navigate, Design (AND)™ Platform continually learns the rules for identifying optimal localizer

Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rar

Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realiz

TurnCare offer cost-effective and user-friendly technology that restores the benefits of healthy movement for patients.

Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our

At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies,

Jade Biosciences is developing a pipeline of potentially best-in-class therapies aimed at transforming the standard of care for patients living with autoimmune diseases.

1MED, is the leading European MedTech specialized solutions provider, offering end-to-end development expertise within the medical device, novel technology and combination products fields. Founded in 2014, with headquarter in Agno, Switzerland, and employing 100+ professionals across the Europe, 1M

Aardvark Therapeutics is a clinical stage biopharmaceutical company focused on developing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications.

Our mission is to deliver evidence-driven, personalized therapies that combat difficult-to-treat and drug-resistant infections. Restoring hope for patients with no remaining options and broadening access to life-changing care.

Talisman Therapeutics is a human stem cell drug discovery company, based in Cambridge, UK. We are committed to revolutionising the discovery of treatments for Alzheimer’s disease (AD). Our novel human stem cell models of AD provide a transformative platform for rapid and more therapeutically relevan

Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and multiple therapeutic areas such as neuroscience, psychiatry, substance abuse

Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and se

Novel Bio makes radically better plasmid DNA for genetic medicines. Accelerate your pipeline with reliable, high-quality plasmids for even your toughest designs, delivered by real DNA experts. We aim to overcome the DNA bottleneck and help bring a new generation of medicine to patients.

Juno develops a compact, discreet and wearable device that alleviates menstrual pain quickly – for a lasting relief.

Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.

Brill Pharma investiga, desarrolla, produce y comercializa fármacos innovadores y con licencia propia con el propósito de mejorar la salud y la calidad de vida de la sociedad. 

 Con este objetivo mantiene, junto al médico y al farmacéutico, un firme compromiso en el tratamiento de la salud de las p

P&C Labs is a specialty pharmaceutical company that addresses critical needs for niche markets by developing and manufacturing a portfolio of high value solid, semi-solid and liquid products. P&C Labs offers an assortment of prescription products that treat tuberculosis infections, and metabolic and

SMART ORTHOPAEDIC TRAUMA IMPLANTS MADE IN SWITZERLAND Founded in 2018, Bonebridge is a Swiss medical device manufacturer dedicated to the design, development, production, and successful application of orthopaedic trauma implants. Our mission is to improve patient outcomes by applying and promoting

Life Biologics specializes in amniotic tissue grafts for advanced wound care, focusing on innovation and quality. We equip healthcare professionals with modern solutions for tissue regeneration.

Optime Care creates partnerships for personalized care with a specific focus on disorders affecting smaller patient communities. Our team of experts in rare disorders works with healthcare providers, payers, biopharmaceutical companies, and patients to implement therapies and support services quick

At Karyon Bio, our interdisciplinary team of scientists, researchers, and AI experts are dedicated to transforming the early detection and treatment of Non-alcoholic fatty liver (NAFL) and Non-alcoholic steatohepatitis (NASH) liver disorders.

Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target